The United States market has shown positive momentum, climbing 2.7% in the last week and up 13% over the past year, with earnings anticipated to grow by 15% annually in the coming years. In this favorable environment, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability to capitalize on these upward trends.
Name
Revenue Growth
Earnings Growth
Growth Rating
Super Micro Computer
24.99%
39.09%
★★★★★★
Mereo BioPharma Group
53.64%
66.60%
★★★★★★
Ardelyx
21.03%
60.42%
★★★★★★
TG Therapeutics
26.46%
38.75%
★★★★★★
Legend Biotech
26.68%
57.96%
★★★★★★
AVITA Medical
27.42%
61.05%
★★★★★★
Alnylam Pharmaceuticals
23.69%
60.42%
★★★★★★
Alkami Technology
20.53%
76.67%
★★★★★★
Ascendis Pharma
35.07%
59.92%
★★★★★★
Lumentum Holdings
22.99%
103.97%
★★★★★★
Click here to see the full list of 226 stocks from our US High Growth Tech and AI Stocks screener.
Let’s dive into some prime choices out of from the screener.
Simply Wall St Growth Rating: ★★★★★★
Overview: Alvotech, with a market cap of $2.77 billion, operates globally through its subsidiaries to develop and manufacture biosimilar medicines for patients.
Operations: With a focus on biotechnology, Alvotech generates revenue of $587.89 million by developing and manufacturing biosimilar medicines globally.
Alvotech’s recent strategic maneuvers, including a beneficial debt refinancing that will save the company $8.2 million in interest payments over the next year, underscore its robust financial management and operational efficiency. This move, coupled with the positive outcomes from their latest clinical trials for AVT23, a biosimilar to Xolair, highlights Alvotech’s commitment to expanding its biosimilar portfolio. The firm has also secured multiple commercial partnerships across global markets, enhancing its distribution capabilities and market reach. These developments not only reflect Alvotech’s agility in navigating complex biotech landscapes but also bolster its position in competitive biosimilar markets.
ALVO Revenue and Expenses Breakdown as at Jun 2025
Simply Wall St Growth Rating: ★★★★☆☆
Overview: AvePoint, Inc. offers a cloud-native data management software platform across multiple regions including North America, Europe, the Middle East, Africa, and the Asia Pacific with a market capitalization of $3.82 billion.
Operations: The company generates revenue primarily through its software and programming segment, which recorded $349.01 million. It operates across various global regions, focusing on cloud-native data management solutions.
Story Continues
AvePoint’s recent advancements underscore its strategic positioning within the tech sector, particularly in enhancing data governance and security for managed service providers (MSPs). With a robust annual revenue growth of 18.3% and earnings projected to surge by 93.7% annually, AvePoint is capitalizing on significant market opportunities. Recent product launches like the Optimization and ROI Command Center reflect a deep understanding of enterprise needs for cost efficiency and robust data management—critical as businesses increasingly rely on multi-cloud strategies. These innovations not only cater to immediate client needs but also position AvePoint favorably in a competitive landscape, suggesting promising prospects for sustained growth and market penetration.
AVPT Earnings and Revenue Growth as at Jun 2025
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Verint Systems Inc. offers customer engagement solutions on a global scale and has a market capitalization of approximately $1.09 billion.
Operations: The company generates revenue primarily from its customer engagement segment, which accounts for $896.01 million.
Verint Systems is distinguishing itself in the high-tech sector, particularly through its AI-driven solutions that are reshaping customer and employee experiences. With a notable earnings growth of 76.7% over the past year, surpassing the software industry’s average of 18.9%, Verint demonstrates robust performance and potential for future expansion. Recent strategic client engagements, like the expanded use with BT Group which now utilizes Verint’s AI bots across 4,500 agents, underscore its capability to scale operations effectively while enhancing productivity and customer satisfaction. This approach not only solidifies its market position but also aligns with industry trends towards integrating human and AI workforce solutions, promising continued relevance and growth in a rapidly evolving tech landscape.
VRNT Revenue and Expenses Breakdown as at Jun 2025
Click here to access our complete index of 226 US High Growth Tech and AI Stocks.
Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ALVO AVPT and VRNT.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
